Market Closed -
OTC Markets
20:58:31 05/06/2024 BST
5-day change
1st Jan Change
0.272
USD
-1.98%
-9.63%
+61.90%
Presentation Operator MessageOperator (Operator)Good afternoon, everyone, and welcome to the B...
Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-14
CI
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
04-02
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
04-01
CI
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
02-12
CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
01-29
CI
BioLargo, Inc. announced that it has received $0.815 million in funding
01-22
CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
12-20
CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
12-12
CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
11-20
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
11-16
CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023
16/08/23
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/08/23
CI
Transcript : BioLargo, Inc., Q1 2023 Earnings Call, May 18, 2023
18/05/23
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
17/05/23
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Apr 03, 2023
03/04/23
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
31/03/23
CI
BioLargo, Inc. Auditor Raises 'Going Concern' Doubt
30/03/23
CI
Biolargo, Inc. Announces Revenue Results for the Year 2022
09/01/23
CI
BioLargo, Inc. announced that it expects to receive $10 million in funding from Lincoln Park Capital, LLC
12/12/22
CI
Biolargo, Inc. Announces That the Pooph Pet Odor Control Product Line Is Now Available At Select Walmart Stores
22/11/22
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Nov 16, 2022
16/11/22
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/11/22
CI
Biolargo, Inc. Announces Board and Committee Changes
03/11/22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
More about the company
Last Close Price
0.2775
USD
Average target price
0.35
USD
Spread / Average Target
+26.13%
Consensus
1st Jan change
Capi.
+61.90% 82.37M +4.86% 104B -10.06% 60.79B +64.76% 51.13B +14.74% 38.21B -0.02% 30.75B +11.82% 19.83B +10.49% 16.5B +7.90% 13.82B -4.54% 13.33B
Other Commodity Chemicals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1